6 viral diseases

Everest Medicines Receives Approval of Investigational New Drug Application from China NMPA for EVER001, a Novel BTK Inhibitor in Development for Treatment of

Advancement highlights Everest’s potential in providing first-in-class therapies to global patients with glomerular disease SHANGHAI, Sept.…

After having her large intestine removed, Caitlin Kimpton awaits two more major surgeries to help with…